Intratumor heterogeneity in clear cell renal cell carcinoma: a review for the practicing pathologist
- PMID: 26865355
- DOI: 10.1111/apm.12500
Intratumor heterogeneity in clear cell renal cell carcinoma: a review for the practicing pathologist
Abstract
Intertumor heterogeneity, defined as the spectrum of morphological differences found in similar tumors in different patients, is a well-known event for pathologists. However, recent molecular studies have pointed to intratumor heterogeneity as one of the most important issues in human neoplasia in the next years. Clear cell renal cell carcinoma is an example of an intrinsically heterogeneous neoplasm, and some of the most salient advances in the knowledge of intratumor heterogeneity have been developed on it. This review intends to analyze this phenomenon in this tumor from the practicing pathologist's point of view. A careful study of the surgical specimen and an exhaustive tumor sampling are mandatory to keep relevant information. Currently accepted protocols designed for renal tumor sampling may be insufficient. As a result, a different approach to tumor sampling is advisable to ascertain that intratumor heterogeneity, if present, will be well represented in the selected material.
Keywords: Clear cell renal cell carcinoma; histopathology; immunohistochemistry; intratumor heterogeneity; molecular pathology.
© 2016 APMIS. Published by John Wiley & Sons Ltd.
Similar articles
-
Snail heterogeneity in clear cell renal cell carcinoma.BMC Cancer. 2016 Mar 8;16:194. doi: 10.1186/s12885-016-2237-x. BMC Cancer. 2016. PMID: 26951092 Free PMC article.
-
Pathological Bases and Clinical Impact of Intratumor Heterogeneity in Clear Cell Renal Cell Carcinoma.Curr Urol Rep. 2018 Jan 27;19(1):3. doi: 10.1007/s11934-018-0754-7. Curr Urol Rep. 2018. PMID: 29374850 Review.
-
High levels of intratumor heterogeneity characterize the expression of epithelial-mesenchymal transition markers in high-grade clear cell renal cell carcinoma.Ann Diagn Pathol. 2018 Jun;34:27-30. doi: 10.1016/j.anndiagpath.2018.01.001. Epub 2018 Jan 10. Ann Diagn Pathol. 2018. PMID: 29661723
-
Heterogeneity in renal cell carcinoma.Urol Oncol. 2017 Aug;35(8):507-515. doi: 10.1016/j.urolonc.2017.05.006. Epub 2017 May 24. Urol Oncol. 2017. PMID: 28551412 Review.
-
A divide-and-conquer strategy in tumor sampling enhances detection of intratumor heterogeneity in routine pathology: A modeling approach in clear cell renal cell carcinoma.F1000Res. 2016 Mar 22;5:385. doi: 10.12688/f1000research.8196.2. eCollection 2016. F1000Res. 2016. PMID: 27127618 Free PMC article.
Cited by
-
Applicability of the regression approach for histological multi-class grading in clear cell renal cell carcinoma.Regen Ther. 2025 Jan 25;28:431-437. doi: 10.1016/j.reth.2025.01.011. eCollection 2025 Mar. Regen Ther. 2025. PMID: 39925965 Free PMC article.
-
Complexity in radiological morphology predicts worse prognosis and is associated with an increase in proteasome component levels in clear cell renal cell carcinoma.Front Oncol. 2022 Dec 8;12:1039383. doi: 10.3389/fonc.2022.1039383. eCollection 2022. Front Oncol. 2022. PMID: 36568232 Free PMC article.
-
The Role of Epigenetics in the Progression of Clear Cell Renal Cell Carcinoma and the Basis for Future Epigenetic Treatments.Cancers (Basel). 2021 Apr 25;13(9):2071. doi: 10.3390/cancers13092071. Cancers (Basel). 2021. PMID: 33922974 Free PMC article. Review.
-
Features of increased malignancy in eosinophilic clear cell renal cell carcinoma.J Pathol. 2020 Dec;252(4):384-397. doi: 10.1002/path.5532. Epub 2020 Sep 24. J Pathol. 2020. PMID: 32815150 Free PMC article.
-
DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects.Mol Diagn Ther. 2016 Dec;20(6):531-549. doi: 10.1007/s40291-016-0231-2. Mol Diagn Ther. 2016. PMID: 27501813 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials